Pharma News

Caraco and Sun to merge

Home/Pharma News | Posted 01/04/2011

Caraco Pharmaceutical Laboratories announced on 22 February 2011 that it had entered into a merger agreement with generics manufacturer Sun Pharmaceutical Industries and its wholly-owned subsidiary Sun Pharma Global.

FDA rejects second citizen petition for Teva’s glatiramer acetate drug

Home/Pharma News | Posted 04/06/2010

Teva Pharmaceutical Industries’ glatiramer acetate drug (Copaxone) is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.

Mylan in and out of hot water

Home/Pharma News | Posted 18/03/2011

On 26 January 2011 Mylan, the second-largest US generics manufacturer, announced a truce with global pharma giant Pfizer, which will enable the former to sell generic versions of the cholesterol drug Lipitor (atorvastatin) and combination blood pressure and cholesterol treatment Caduet (amlodipine/atorvastatin).

Valeant acquires generics’ manufacturer PharmaSwiss

Home/Pharma News | Posted 11/03/2011

Valeant Pharmaceuticals International and PharmaSwiss announced on 1 February 2011 that they had signed a binding agreement for Valeant to acquire generics’ manufacturer PharmaSwiss for Euros 350 million. Valeant expects the deal to strengthen its presence in Central and Eastern Europe.

Rights to Allegra acquired by generics’ manufacturer Perrigo

Home/Pharma News | Posted 10/08/2010

On 29 June 2010, Perrigo announced that it had acquired the exclusive US rights to sell and distribute OTC versions of Fexofenadine HCl 180 mg and 60 mg tablets, plus Fexofenadine HCl 60 mg and Pseudoephedrine 120 mg tablets, the generic versions of sanofi-aventis’ Allegra and Allegra D-12 products. Teva Pharmaceutical Industries currently has prescription (Rx) approval for these products, and Teva and sanofi-aventis have settled their Paragraph IV litigation.

Perrigo buys Paddock for US$540 million

Home/Pharma News | Posted 04/03/2011

Perrigo Company may not be a household name, but nevertheless life is exciting for a medium-sized company in the pharmaceuticals world. Undeterred by a pending FDA warning letter about its Michigan facility, Perrigo recently entered into a definitive agreement to take over Paddock Laboratories in a cash deal worth Euros 394 million.

Teva increases stake in Mediwound to 51%

Home/Pharma News | Posted 11/02/2011

Israel’s Teva Pharmaceutical Industries is increasing its stake in biotechnology company MediWound Ltd to 51% under a multi-tiered deal to develop and commercialise products to treat burns and wounds.

Ranbaxy’s profits soar, but US ban still looms

Home/Pharma News | Posted 04/02/2011

The generics’ giant and India’s largest pharmaceutical manufacturer, Ranbaxy, has reported strong results for the third quarter of 2010, but concerns remain about the US import ban that is still in place on many of the firm’s generics.

Cost of new drug challenged

Home/Pharma News | Posted 21/01/2011

An editorial in the New England Journal of Medicine (NEJM) issue of 23 September 2010 took the unusual position of challenging a study published in the same issue.

Pfizer buys 40% stake in Brazilian generics’ manufacturer Teuto

Home/Pharma News | Posted 21/01/2011

Pfizer, the world's biggest pharma company, is increasing its stake in emerging markets, with its announcement on 20 October 2010 that it has entered into an agreement to acquire a 40% stake in Brazilian generics’ manufacturer Laboratorio Teuto Brasileiro (Teuto) for US$240 million.